NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
The target population of the trial consists of patients with locally advanced irresectable or metastatic solid malignancies, such as advanced thyroid cancer, squamous cell carcinoma originating from head and neck region, vulvar or cervix squamous cell carcinoma, and non-small cell lung cancer.
1 total trials1 recruiting
Filter these 1 trials by phase, country, sponsor and more.